GlassScriptPhysician profile
Jack Parks Arthur
NPI 1922763069
$1,509.66
in general payments reported to CMS, 2019-2025
13 companies · $725 in 2025
The $725 reported for 2025 was more than what 86% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $102 · 2023: $42.83 · 2024: $639 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,407.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $851.34 | 2024-2025 | N/A, Prostep Mica, Augment Injectable |
| Depuy Synthes Sales INC. | $222.88 | 2024-2025 | Hammerlock, Na, Motoband |
| Abbvie INC. | $100.46 | 2023-2025 | |
| Smith+Nephew, INC. | $84.85 | 2025 | Na, Grafix Pl |
| Peerless Surgical INC. | $68.34 | 2024-2025 | |
| Inari Medical, INC. | $40.92 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $36.30 | 2022 | |
| Davol INC. | $22.72 | 2024 | Phasix Mesh |
| Medela LLC | $18.94 | 2022 | |
| Braintree Laboratories, INC. | $16.72 | 2022 | |
| Integra Lifesciences Corporation | $16.50 | 2022 | |
| Solventum Corporation | $15.72 | 2024 | Prevena |
| Pacira Pharmaceuticals Incorporated | $13.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Arthur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.